Works matching IS 13570560 AND DT 2024 AND VI 41 AND IP 9
Results: 27
Letter to the editor: Comment on "Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Immunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02480-9
- By:
- Publication type:
- Article
The potential of lenvatinib in breast cancer therapy.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02477-4
- By:
- Publication type:
- Article
2023 ACS – LANA lymphedema summit forward momentum; future steps in lymphedema management.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02475-6
- By:
- Publication type:
- Article
Therapeutic response and safety of radioligand therapy with <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02466-7
- By:
- Publication type:
- Article
A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02473-8
- By:
- Publication type:
- Article
Diverse roles of aldolase enzymes in cancer development, drug resistance and therapeutic approaches as moonlighting enzymes.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02470-x
- By:
- Publication type:
- Article
Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02469-4
- By:
- Publication type:
- Article
Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02468-5
- By:
- Publication type:
- Article
Moscatilin, a potential therapeutic agent for cancer treatment: insights into molecular mechanisms and clinical prospects.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02467-6
- By:
- Publication type:
- Article
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02471-w
- By:
- Publication type:
- Article
Tetrahydroisoquinoline reduces angiogenesis by interacting myeloma cells with HUVECs mediated by extracellular vesicles.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02465-8
- By:
- Publication type:
- Article
Emerging roles of the chromatin remodeler MORC2 in cancer metabolism.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02464-9
- By:
- Publication type:
- Article
Comment on 'Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression'.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02462-x
- By:
- Publication type:
- Article
Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02461-y
- By:
- Publication type:
- Article
Comment on "Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi-receptor approach for potential therapeutic agents in colorectal cancer".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Allicin: a promising modulator of apoptosis and survival signaling in cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02459-6
- By:
- Publication type:
- Article
Mining parasites for their potential as novel therapeutic agents against cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02458-7
- By:
- Publication type:
- Article
Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02455-w
- By:
- Publication type:
- Article
Exploring the potential of tocopherols: mechanisms of action and perspectives in the prevention and treatment of breast cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02454-x
- By:
- Publication type:
- Article
Current advances in cancer energy metabolism under dietary restriction: a mini review.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02452-z
- By:
- Publication type:
- Article
Targeted gene therapy for cancer: the impact of microRNA multipotentiality.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02450-1
- By:
- Publication type:
- Article
Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 9, p. 1, doi. 10.1007/s12032-024-02448-9
- By:
- Publication type:
- Article
Letters to editor regarding the article "P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway".
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Correction to: Auraptene‑induced cytotoxic effects in acute myeloid leukemia cell Lines.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice